Conmed (CNMD) Misses Q4 EPS by 5c, offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- US stock futures gain as oil pulls back ahead of Fed decision
- Nvidia to commit $3 bln to Meta share offering as part of bigger AI partnership
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Boeing free cash flow beats estimates despite production challenges
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $47.68 --0%
Revenue Growth %: -0.5%
Financial Fact:
Research and development expense: 8.35M
Today's EPS Names:
OMID, SICP, SCKT, More
Revenue Growth %: -0.5%
Financial Fact:
Research and development expense: 8.35M
Today's EPS Names:
OMID, SICP, SCKT, More
Join SI Premium – FREE
Conmed (NYSE: CNMD) reported Q4 EPS of $1.06, $0.05 worse than the analyst estimate of $1.11. Revenue for the quarter came in at $327 million versus the consensus estimate of $332.22 million.
GUIDANCE:
Conmed sees FY2024 EPS of $4.30-$4.40, versus the consensus of $4.40. Conmed sees FY2024 revenue of $1.34-1.365 billion, versus the consensus of $1.357 billion.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CTS Corp. (CTS) Tops Q3 EPS by 10c ; Offers Guidance
- PayPal (PYPL) Tops Q3 EPS by 14c; lifts EPS guidance
- Ecolab (ECL) Tops Q3 EPS by 1c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
